Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hematologic abnormalities in patients with nonhematologic malignancies.

J P Dutcher1

  • 1Albert Einstein College of Medicine, Bronx, New York.

Hematology/Oncology Clinics of North America
|June 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overall survival by clinical risk category for high dose interleukin-2 (HD IL-2) treated patients with metastatic renal cell cancer (mRCC): data from the PROCLAIM<sup>SM</sup> registry.

Journal for immunotherapy of cancer·2019
Same author

A phase I study of cabozantinib (XL184) in patients with renal cell cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

Characterization of bone metastases in patients with renal cell cancer.

BJU international·2004
Same author

Accelerated and blastic phase of chronic myeloid leukemia.

Current treatment options in oncology·2002
Same author

Phase I study of recombinant human CD40 ligand in cancer patients.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
Same author

Angiogenesis and melanoma.

Current oncology reports·2001
Same journal

Palliative Therapy for Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Ablative Therapies for Liver Tumors.

Hematology/oncology clinics of North America·2026
Same journal

Pathology of Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery for Liver and Biliary Tract Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Surgical Considerations for Primary Liver Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Systemic Therapy for Biliary and Liver Neoplasms: Chemotherapy and Immunotherapy.

Hematology/oncology clinics of North America·2026
See all related articles

Hematologic abnormalities frequently occur in nonhematologic cancer patients, impacting patient outcomes. Understanding these blood-related issues helps physicians manage complications and determine necessary interventions.

Area of Science:

  • Hematology
  • Oncology
  • Internal Medicine

Background:

  • Hematologic abnormalities are common in patients with nonhematologic malignancies.
  • These abnormalities can significantly contribute to patient morbidity and mortality.

Purpose of the Study:

  • To provide physicians with an understanding of the spectrum of hematologic abnormalities in nonhematologic malignancies.
  • To enable anticipation and amelioration of these complications.
  • To guide decisions regarding the necessity of intervention.

Main Methods:

  • This abstract does not detail specific methods.
  • The content implies a review or synthesis of existing knowledge.

Main Results:

Related Experiment Videos

  • Hematologic abnormalities are a significant clinical issue in nonhematologic cancer patients.
  • Understanding the causes and severity is key to patient management.

    • Conclusions:

    • Physicians need to appreciate the range and causes of hematologic abnormalities in these patients.
    • This knowledge aids in anticipating, managing, and deciding on interventions for complications.